What Signum Technologies does

Signum Technologies is a privately held Delaware-incorporated computer vision and AI company founded in 2022 and headquartered in Radnor, Pennsylvania. The company develops ROSIE, a patented passive optical physiology monitoring software that uses video and image analysis to detect vital sign anomalies in individuals without physical contact, enabling population-scale contactless health screening and continuous clinical monitoring. The company's core technology is positioned across two primary verticals: health security, where it targets U.S. federal agencies such as TSA, DHS, and CBP for screening at airports, maritime ports, and border crossings; and healthcare, where it sells to hospitals, burn centers, NICUs, senior living facilities, and telehealth providers for contactless vital sign monitoring and remote diagnostics.

Signum was incubated through FedTech, a U.S. government-funded technology incubator that selected the founding team to commercialize biosensor technology originally developed in response to Covid-19-era healthcare and security needs. The company maintains strategic innovation-partner relationships with MITRE, U.S. National Laboratories, and federal agencies, and lists a separate PenFed Foundation grant in its funding history. Its leadership team is led by Sean Freitag (CEO, former Blackstone Principal and 14-year U.S. Navy SEAL), Andrew Gehman (COO, founder of Black Eagle Defense), and Mark Farmer (CTO, 24-year software engineering veteran).

The business model is enterprise sales-led with no publicly disclosed pricing, no published ARR or customer logos, and a stated headcount of 1–10 employees. The company is pre-commercial in terms of disclosed revenue and is currently raising capital; as of March 2026, an SEC Form D exempt securities offering had raised approximately $1.2 million toward a $1.725 million target, with $200,000 of gross proceeds allocated to executive and director compensation. Geographic footprint is domestic (USA) and the company has no disclosed international operations.

Name

Signum Technologies

Legal name

Signum Technologies, Inc.

Website

https://signum-tech.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

1–10 employees

Short description

Signum Technologies is a U.S. computer vision and AI company building ROSIE, a patented contactless vital sign monitoring platform, and selling it to federal agencies for health-security screening at airports, ports, and borders, and to healthcare providers for remote patient monitoring.

Ownership category

akta.pro rank

Headquarters

HQ city

Radnor

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Others

Revenue model

1. SEC Exempt Securities Offering: The company is raising capital through SEC Form D exempt securities offering targeting $1,725,000 with $1,199,999 already sold. $200,000 of gross proceeds allocated to executive and director payments.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels3 records

Core offering

Signum Technologies develops and sells ROSIE, a patented passive optical physiology monitoring software that uses computer vision and artificial intelligence to perform contactless vital sign monitoring. The product scans individuals in bulk to identify those whose vital signs fall outside normal parameters without any physical contact, enabling deployment in healthcare (senior living, NICUs, burn centers, telehealth) and government health security (airports, ports, border crossings) settings.

Product overview

Signum Technologies offers a unified product portfolio centered on ROSIE, their patented passive optical physiology monitoring software. The core ROSIE product enables contactless vital sign monitoring through computer vision and AI, supporting two main solution categories: Healthcare Solutions (covering senior living, burn centers, NICUs, and telehealth integration) and Health Security Solutions (for airports, ports, and border crossings). All offerings leverage the same underlying ROSIE technology platform for passive optical scanning of vital signs without patient contact.

Differentiator

Problem solved

Functional benefit

Brands

• ROSIE: Patented passive optical physiology monitoring software that enables scanning of large numbers of individuals and quickly identifies individuals whose vital signs are outside normal parameters without patient contact. Used for vital sign monitoring in healthcare and health security applications.

Products and services

• ROSIE Vital Sign Monitoring Patented passive optical physiology monitoring software that uses computer vision and AI to scan large numbers of individuals and quickly identify those whose vital signs are outside normal parameters, providing initial health assessment without any patient contact. Used by federal agencies for health screening at critical infrastructure (airports, ports, border crossings) and by healthcare providers for contactless patient monitoring.

Quantifiable outcome

• Enables scanning of large numbers of individuals to quickly identify vital sign anomalies
• +3 more outcomes

Segments3 records

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature2 records

Partnerships

Five partnerships are on record, tiered core and minor.

• FedTechcoreStrategic or Co-development Partner · 1 January 2022Signum Technologies was founded in 2022 in collaboration with FedTech, a USG funded technology incubator. FedTech selected Signum to commercialize groundbreaking biosensor technology developed in response to urgent healthcare and security needs arising from the Covid-19 pandemic. FedTech serves as a deep tech innovation catalyst for the company.
• MITREcoreStrategic or Co-development PartnerMITRE is listed as an innovation partner of Signum Technologies. The partnership contributes to the company's mission of transforming state-of-the-art technologies into tangible solutions for society's most pressing challenges.
• US National LaboratoriescoreStrategic or Co-development PartnerSignum Technologies collaborates closely with US National Laboratories to transform state-of-the-art technologies into tangible solutions that tackle society's most pressing challenges. The company works at the forefront of innovation using advanced tools to address critical problems facing humanity.
• Federal AgenciescoreStrategic or Co-development PartnerSignum Technologies collaborates with Federal Agencies as part of its mission to transform state-of-the-art technologies into solutions addressing society's most pressing challenges. The company leverages these partnerships to develop and deploy health security technologies.
• Navy SEAL FoundationminorOthersSean Freitag, CEO of Signum Technologies, serves on the board of directors of the Navy SEAL Foundation, which provides immediate and ongoing support and assistance to the Naval Special Warfare community and its families. This represents a personal leadership commitment rather than a commercial partnership.

Scale indicators3 records

Recent moves6 records

Expansion highlights5 records

Emerging players

• EarlySense: Contact-free continuous patient monitoring for hospitals and senior living, competing for the same clinical RPM and senior-living safety budgets that Signum targets.
• Care.ai: AI-powered ambient sensing platform for healthcare facilities that combines computer vision with vital sign and behavior monitoring, overlapping Signum's healthcare and telehealth vision.
• BioIntellisense: Continuous health monitoring via wearable and contact-free sensors for clinical RPM, an adjacent competitor for the same healthcare and senior-living decision-makers.
• Xandar Kardian: Radar-based vital sign and occupancy monitoring for healthcare and smart-building applications, an adjacent contactless monitoring peer competing for similar remote patient and facility monitoring budgets.
• Biovitals: Contactless physiological monitoring using video analysis for clinical and remote patient use cases, a closer emerging competitor in the same contactless vitals category.
• Aerial: Computer vision platform for contact-free health monitoring in senior living and home care, addressing the same elderly/frail and assisted-living customer segment as Signum.

Direct peers

• Binah.ai: Provides contactless vital signs monitoring (heart rate, SpO2, blood pressure, stress) via video from smartphones or cameras, directly overlapping ROSIE's core passive optical physiology capability across both healthcare and workforce screening.
• NuraLogix: Developer of TransDERMAL and Anura platforms that extract vital signs and health risk indicators from video, a direct technological analogue to ROSIE's AI/computer-vision vital sign approach.
• Oxehealth: Uses cameras and computer vision for contactless vital sign and activity monitoring in clinical and senior care settings, closely mirroring Signum's healthcare and senior living use cases.

Broad incumbents

• Anduril Industries: Large defense-tech incumbent building AI sensing and surveillance for DHS/CBP and other federal agencies; a strategic reference point for AI-driven critical-infrastructure security customers that Signum is also targeting.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks5 records

Key highlights5 records

Customer concentration

Revenue estimate

Valuation estimate

Number of profiles

Profiles3 records

Funding overview

Funding rounds2 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Signum Technologies